These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30424514)

  • 1. Oral Adjuvant Curcumin Therapy for Attaining Clinical Remission in Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Grammatikopoulou MG; Gkiouras K; Theodoridis X; Asteriou E; Forbes A; Bogdanos DP
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30424514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Curcumin as Adjuvant Therapy to Induce or Maintain Remission in Ulcerative Colitis Patients: an Evidence-based Clinical Review.
    Simadibrata M; Halimkesuma CC; Suwita BM
    Acta Med Indones; 2017 Oct; 49(4):363-368. PubMed ID: 29348389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferons for induction of remission in ulcerative colitis.
    Seow CH; Benchimol EI; Griffiths AM; Steinhart AH
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006790. PubMed ID: 18646167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.
    Coelho MR; Romi MD; Ferreira DMTP; Zaltman C; Soares-Mota M
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.
    Lang A; Salomon N; Wu JC; Kopylov U; Lahat A; Har-Noy O; Ching JY; Cheong PK; Avidan B; Gamus D; Kaimakliotis I; Eliakim R; Ng SC; Ben-Horin S
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1444-9.e1. PubMed ID: 25724700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin therapy for ulcerative colitis remission: systematic review and meta-analysis.
    Goulart RA; Barbalho SM; Rubira CJ; Araújo AC; Lima VM; Rogerio Leoni B; Guiguer EL
    Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1171-1179. PubMed ID: 32772752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of adjuvant curcumin therapy in ulcerative colitis: A meta-analysis of randomized controlled trials.
    Zheng T; Wang X; Chen Z; He A; Zheng Z; Liu G
    J Gastroenterol Hepatol; 2020 May; 35(5):722-729. PubMed ID: 31696975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate for maintenance of remission in ulcerative colitis.
    El-Matary W; Vandermeer B; Griffiths AM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007560. PubMed ID: 19588435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal nicotine for induction of remission in ulcerative colitis.
    McGrath J; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004722. PubMed ID: 15495126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME; Seow CH; Steinhart AH; Griffiths AM
    Cochrane Database Syst Rev; 2010 Oct; (10):CD007698. PubMed ID: 20927762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Curcumin in Achieving Clinical and Endoscopic Remission in Ulcerative Colitis: A Systematic Review and Meta-analysis.
    Iqbal U; Anwar H; Quadri AA
    Am J Med Sci; 2018 Oct; 356(4):350-356. PubMed ID: 30360803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of adjuvant curcumin therapy in ulcerative colitis: A systematic review and meta-analysis.
    Yin J; Wei L; Wang N; Li X; Miao M
    J Ethnopharmacol; 2022 May; 289():115041. PubMed ID: 35091013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study.
    Singla V; Pratap Mouli V; Garg SK; Rai T; Choudhury BN; Verma P; Deb R; Tiwari V; Rohatgi S; Dhingra R; Kedia S; Sharma PK; Makharia G; Ahuja V
    J Crohns Colitis; 2014 Mar; 8(3):208-14. PubMed ID: 24011514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Andoh A; Tsujikawa T; Fujiyama Y; Mitsuyama K; Sata M; Yamada M; Iwaoka Y; Kanke K; Hiraishi H; Hirayama K; Arai H; Yoshii S; Uchijima M; Nagata T; Koide Y
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1502-6. PubMed ID: 17101300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
    Jairath V; Zou G; Parker CE; Macdonald JK; Mosli MH; Khanna R; Shackelton LM; Vandervoort MK; AlAmeel T; Al Beshir M; AlMadi M; Al-Taweel T; Atkinson NS; Biswas S; Chapman TP; Dulai PS; Glaire MA; Hoekman D; Koutsoumpas A; Minas E; Samaan MA; Travis S; D'Haens G; Levesque BG; Sandborn WJ; Feagan BG
    J Crohns Colitis; 2016 May; 10(5):607-18. PubMed ID: 26746169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ
    Cochrane Database Syst Rev; 2010 Jan; (1):CD004115. PubMed ID: 20091560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Chen X; Hou J; Yuan Y; Huang C; Liu T; Mo C; Li H; Chen B; Xu Q; Hou Z; He W; Liu F
    BioDrugs; 2016 Jun; 30(3):207-17. PubMed ID: 27120055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness and safety of curcumin as a complementary therapy in inflammatory bowel disease: A protocol of systematic review and meta-analysis.
    Yang Z; Liu W; Zhou X; Zhu X; Suo F; Yao S
    Medicine (Baltimore); 2020 Oct; 99(43):e22916. PubMed ID: 33120843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.